Ilant provides comprehensive, employer-backed metabolic care. Drive meaningful health outcomes with expert clinical guidance, care teams, and managed GLP-1 plans.
Location: United States
Total raised: $20.5M
Investors 2
| Date | Name | Website |
| - | Celtic Hou... | celticvc.c... |
| - | AlphaLab H... | alphalabhe... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.06.2026 | Series A | $15M | PeakBridge... |
| 23.04.2024 | Seed | $5.5M | - |
Mentions in press and media 20
| Date | Title | Description |
| 11.08.2026 | From GLP-1s to biosensors: Inside Cornucopian Capital’s precision health playbook | Is precision health tech a gamechanger that could move the needle on public health, or are its benefits confined to a small cohort of affluent, health-conscious consumers seeking to fine-tune their wellness? While early adopters of high-tec... |
| 01.08.2026 | As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners | To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo As employers drop GLP-1 coverage, more Americans are being encouraged to use direct-to-consumer (DTC) weight-loss drug prescription programs. Major retailers and pharmacy ... |
| 09.06.2026 | Ilant Health Nabs $15M Series A Financing | NEW YORK, NY, Ilant Health announced it has raised $15 million in Series A funding. >> Click here for more funding data on Ilant Health >> To export Ilant Health funding data to PDF and Excel, click here Ilant Health, the value... |
| 04.06.2026 | Ilant Health raises $15M to use AI for obesity care as employers rethink costly GLP-1 coverage | The obesity drug boom promised a breakthrough in healthcare. It delivered one. It brought a new problem, too. Employers across the United States are facing soaring costs tied to popular GLP-1 weight-loss drugs. Some companies have begun sca... |
| 03.06.2026 | Ilant Health Raises $15 Million Series A To Expand AI-Enabled, Value-Based Obesity Care | Ilant Health, a value-based obesity treatment company that works with employers and health plans to improve clinical outcomes while reducing the total cost of care, announced that it has raised $15 million in Series A funding. The financing... |
| 02.06.2026 | Ilant Health Raises $15 Million to Expand Value-Based Obesity Care | Ilant Health Raises New Capital for Growth Ilant Health has raised $15 million in Series A funding. With this latest investment round, the total funding for Ilant has surpassed $22 million. The funding trend toward treatments that manage ob... |
| 02.06.2026 | Ilant Health Secures $15M to Expand Value-Based Precision Obesity Management Defeating the GLP-1 Cost Spiral: Why Ilant Health Raised $15M to Scale Outcomes-as-a-Service | What You Should Know Value-based obesity management leader Ilant Health has closed a $15M Series A funding round led by Cornucopian Capital, elevating its total funding footprint past $22 million. The financing round features strategic part... |
| 05.03.2026 | Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S. | Eli Lilly launched a new program designed to help more employers cover obesity drugs in the U.S., targeting a major barrier to access for patients. The “Employer Connect” platform gives employers more flexibility in how they cover obesity t... |
| 14.05.2025 | Disrupting Obesity Care: Elina Onitskansky Fights Stigma with Smart, Personalized Treatment | DI PRS 175 Obesity affects nearly half of all Americans, yet stigma and ineffective care leave patients behind. Elina Onitskansky of Ilant Health is changing the narrative with an AI-powered, patient-first model that tackles the root causes... |
| 23.04.2024 | Ilant Health Raises Another $2.5M for its Value-Based Care Platform for Obesity Management | Obesity is a pressing health concern affecting 42% of Americans, and its impact reverberates across every state in the union, where at least 20% of the population grapples with this condition. The staggering cost of chronic illnesses linked... |
Show more